Magnetic resonance imaging in multiple sclerosis

Current Opinion in Neurology

Volumn 11, Issue 4, 1998, Pages 299-303

  Clanet, Michel ^a   Berry, Isabelle ^b  

^a CHU PURPAN   (France)

^b CHU RANGUEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

DISEASE ACTIVITY; DISEASE SEVERITY; HISTOLOGY; HUMAN; IMAGING; MULTIPLE SCLEROSIS; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REVIEW;

DIFFUSION; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MULTIPLE SCLEROSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 0031688972     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199808000-00004     Document Type: Review

References (44)

1. Imaging in multiple sclerosis. Proceedings of the MS Forum Modern Management Workshop, Aylesbury, UK, April 1997. Worthing: PPS Europe Ltd; 1997. This is a comprehensive, up-to-date review, with circumstantial explanations of basic methodology that are accessible to neurologists.
2. Miller DH, Grossman RI, Reingold SC, McFarland HF. The role of MR techniques in understanding and managing multiple sclerosis. Brain 1998; 121:3-24. This paper provides an examination of the current understanding of technical issues, role in diagnosis, natural history, application in trials and new techniques. It presents a summary of a magnetic resonance workshop held in Oxford in 1997.
3. Barkhof F, Filippi M, Miller DH, Scheltens P, Campi A, Polman CH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997; 120:2059-2069. A presentation and discussion of the MRI criteria of diagnosis and early prognosis of multiple sclerosis is provided.
4. Paty DW, Oger JJF, Kastrukoff FF, Hashimoto SA, Hooge JP, Eisen AA. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding and CT. Neurology 1988; 38:180-185.
5. Fazekas F, Offenbacher H, Fuchs S, Schmidt R, Niederkorn K, Horne S. Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected MS. Neurology 1988; 38:1822-1825.
6. Bastianello S, Bozzao A, Paolillo A, Giugni E, Gasperini C, Koudriavtseva T, et al. Fast spin-echo and fast fluid-attenuated inversion-recovery versus conventional spin-echo sequences for MR quantification of multiple sclerosis lesions. Am J Neuroradiol 1997; 18:580-582.
7. Filippi M, Yousry TA, Alkadhi H, Stehling M, Horsfield MA, Voltz R. Spinal cord MRI in multiple sclerosis with multicoil arrays: a comparison between fast spin echo and fast flair. J Neurol 1997; 244:76-84.
8. Stevenson VL, Gawne-Cain ML, Barker GJ, Thompson AJ, Miller DH. Imaging of the spinal cord and brain in multiple sclerosis: a comparative study between fast flair and fast spin echo. J Neurol 1997; 244:119-124.
9. Yousry TA, Filippi M, Becker C, Horsfield MA, Voltz R. Comparison of MR pulse sequences in the detection of multiple sclerosis lesions. J Neurol 1997; 244:119-124.
10. Thorpe JW, Kidd D, Moseley IF, Thompson AJ, MacManus DG, Compston DA. Spinal MRI in patients with suspected MS and negative brain MRI. Brain 1996; 119:709-714.
11. Miller DH, Albert PS, Barkhof F, Francis G, Frank JA, Hodgkinson S, et al. Guidelines for the use of MR techniques in monitoring the treatment of MS. Ann Neurol 1996; 39:6-16. This article reviews the use of MRI in multiple sclerosis trials, according to the conclusions of a panel of experts.
12. Silver NC, Good CD, Barker GJ, MacManus DG, Thompson AJ, Moseley IF, et al. Sensitivity of contrast enhanced MRI in multiple sclerosis. Effects of gadolinium dose, magnetization transfer contrast and delayed imaging. Brain 1997; 120:1749-1761.
13. Simon JH, Jacobs LD, Campion M, Wende K, Simonian N, Cookfair DL, et al. Magnetic resonance studies of intramuscular Interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group. Ann Neurol 1998; 43:79-87.
14. Stone LA, Frank JA, Albert PS, Bash C, Smith ME, Maloni H, McFarland HF. The effect of Interferon beta on the brain barrier disruption demonstrated by contrast enhanced MRI in relapsing remitting MS. Ann Neurol 1995; 66:147-151.
15. Tubridy N, Coles AJ, Molyneux P, Compston DAS, Barkhof F, Thompson AJ, et al. Secondary progressive multiple sclerosis: the relationship between short-term MRI activity and clinical features. Brain 1998; 121:225-231.
16. The IFNB Multiple Sclerosis Study Group. University of British Columbia MS/MRI analysis group. Interferon beta-1b in the treatment of MS. Final outcome of the randomized controlled trial. Neurology 1995; 45:1277-1285.
17. Morrissey SP, Stodal H, Zettl U, Simonis C, Jung S, Kiefer R, et al. In vivo MRI and its histological correlates in acute adoptive transfer experimental allergic encephalomyelitis. Quantification of inflammation and oedema. Brain 1996; 119:239-248.
18. Bruck W, Bitsch A, Kolenda H, Bruck Y, Stiefel M, Lassmann H. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 1997; 42:783-793. This is an interesting presentation of the correlations between histological features in acute lesions and MRI.
19. Rudick R, Antel J, Confavreux C, Cutter G, Ellison G, Fischer J, et al. Clinical outcome assessment in MS [review]. Ann Neurol 1996; 40:469-479.
20. Hohol MJ, Guttmann CRG, Oray J, Mackin GA, Kikinis R, Khoury SJ, et al. Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosis. Arch Neurol 1997; 54:1018-1024.
21. Barkhof F, Filippi M, Miller DH, Tofts P, Kappos L, Thompson AJ. Strategies for optimizing MRI techniques aimed at monitoring disease activity in multiple sclerosis treatment trials. J Neurol 1997; 244:76-84.
22. Uhlenbrock D, Sehlen S. The value of T1-weighted images in the differentiation between MS, white matter lesions, and subcorticalarteriosclerotic encephalopathy. Neuroradiology 1989; 13:227-231.
23. van Walderveen MAA, Scheltsten P, van Waesberghe JHTM, Ravid R, Polman CH, Valk J. Hypointense lesions on T1-weighted SE MR images correlate with axonal loss in MS. J Neurol 1997; 244 (Suppl 84):P410.
24. van Walderveen MAA, Barkhof F, Hommes OR, Polman CH, Tobi H, Frequin ST. Correlating MRI and clinical disease activity in MS: relevance of hypointense lesions on short TR/short TE (T1-weighted) spin echo images. Neurology 1995; 45:1684-1690.
25. Wang L, Lai HM, Thompson AJ, Miller DH. Accumulation of hypointense lesions ('black holes') on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology 1996; 47:1469-1476.
26. Losseff NA, Webb SL, O'Riordan JL, Page R, Wang WI, Barker GJ, et al. Spinal cord atrophy and disability in MS: a new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 1996; 119:701-708.
27. Losseff NA, Wang L, Lai HM, Yoo DS, Gawne-Cain ML, McDonald WI, et al. Progressive cerebral atrophy in MS. A serial MRI study. Brain 1996; 119:2009-2019
28. Storch M, Lassmann H. Pathology and pathogenesis of demyelinating diseases. Curr Opin Neurol 1997; 10:186-192. This article describes the different pathogenic mechanisms, reflecting the heterogeneity of pathology and immunological mechanisms of the multiple sclerosis lesions.
29. Arnold DL, Matthews PM, Francis G, Antel J. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of MS: assessment of the load of the disease. Magn Reson Med 1990; 14:154-159.
30. Silver NC, Barker RA, Macmanus DG, Barker GJ, Thom M, Thomas DGT, et al. Proton magnetic resonance spectroscopy in a pathologically confirmed acute demyelinating lesion. J Neurol 1997; 244:204-207.
31. Narayana PA, Doyle TJ, Lai D, Wolinsky JS. Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis. Ann Neurol 1998; 43:56-71. This article presents interesting data on a longitudinal follow up of a series of patients studied by MRI spectroscopy imaging with some new findings about the relationship between demyelination and inflammatory process.
32. Trapp BD, Peterson DH, Ransohof RM, Rudick R, Mork S, Bö L. Axonal transection in the lesions of MS. N Engl J Med 1998; 338:278-285.
33. Narayanan S, Fu L, Pioro E, De Stefano N, Collins DL, Francis GS, et al. Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions. Ann Neurol 1997; 41:385-391.
34. Davie CA, Barker GJ, Thompson AJ, Tofts PS, McDonald WI, Miller DH. 1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis. J Neurol Neurosurg Psychiatry 1997; 63:736-742.
35. Fu L, Matthews PM, De Stefano N, Worsley KJ, Narayanan S, Francis GS. et al. Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain 1998; 121:103-113.
36. Ranjeva JP, Franconi JM, Manelfe C, Berry I. Magnetization transfer with echo planar imaging. MAGMA 1997; 5:259-265.
37. Gass A, Barker GJ, Kidd D, Thorpe JW, MacManus D, Brennan A, et al. Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis. Ann Neurol 1994; 36:62-67.
38. Silver NC, Barker GJ, Losseff NA, Gawne-Cain ML, MacManus DG, Thompson AJ, Miller DHA. Magnetization transfer study of white matter in siblings of multiple sclerosis patients. J Neurol Sci 1997; 147:151-153.
39. Filippi M, Campi A, Martino G, Colombo B, Comi GA. Magnetization transfer study of white matter in siblings of multiple sclerosis patients. J Neurol Sci 1997; 147:151-153.
40. Rovaris M, Filippi M, Calori G, Rodegher M, Campi A, Colombo B, Comi G. Magnetization transfer ratio measurement in the cervical spinal cord: a preliminary study in multiple sclerosis. Neuroradiology 1997; 39:441-447.
41. van Buchem MA, McGowan GC, Kolson DL, Grossman RI. Ouantitative volumetric magnetization transfer analysis in MS. Estimation of macroscopic and microscopic disease burden. Magn Reson Med 1996; 36:632-636. A new method for the estimation of the magnetization transfer ratio variations in the whole brain is presented.
42. Berry I, Barker G, Barkhot F, Campi A, Dousset V, Francono JM, Toffs P. A multicentre measurement of magnetization transfer ratio in normal white matter [abstract]. Proc Int Soc Magn Reson Med 1996; 1:536.
43. Horsfield MA, Lai M, Webb SL, Barker JF, Tofts PS, Turner R. Apparent diffusion coefficient in benign and secondary progressive MS by nuclear MR. Magn Reson Med 1996; 36:393-400.
44. Clanet M, Berry I, Boulanouar K. Functional imaging in MS. Int MS J 1997; 4:26-32.